Skip to main content
Log in

From Spontaneous Adverse Drug Reporting to Legislation Change of Ketorolac in Taiwan

  • Abstract
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. MICROMEDEX® Healthcare Series 2008 edition.

  2. Information retrieved from Taiwan National Health Insurance database was provided by Bureau of National Health Insurance, Taiwan.

  3. Taiwan National Adverse Drug Reaction Reporting electronic database.

  4. Winterstein AG, Hatton RC, Gonzalez-Rothi R, et al. Identifying Significant Preventable Adverse Drug Events. Am J Health-Syst Pharm 2002; 59(18):1742–9

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, W., Gau, C. & Hsieh, Y. From Spontaneous Adverse Drug Reporting to Legislation Change of Ketorolac in Taiwan. Drug-Safety 31, 885 (2008). https://doi.org/10.2165/00002018-200831100-00040

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200831100-00040

Keywords

Navigation